Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study

CONCLUSION: Nicorandil in combination with trimetazidine can be considered as an effective and potential treatment strategy in reducing the rate of MACE in patients with CHD in the Chinese population.PMID:34846710 | DOI:10.1007/s12325-021-01987-1

Source: Adv Data - November 30, 2021 Category: Epidemiology Authors: Lan Shen Lin Qiu Jingbo Liu Na Li Hongyang Shu Ning Zhou Source Type: research